Lauren Howard

15PUBLICATIONS
92CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples cultural determinants of healthMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 05, 2026
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

|Jul 10, 2026
Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

|May 13, 2025
Mitochondrial DNA Copy-Number Assessment Is a Potent Predictor for Prostate Cancer in White but Not Black Individuals.

Melanie K Flores, Jessica L Janes, Mirajul Islam

|Oct 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Yingmiao Liu, Jiatong Li, Jing Lyu

|Aug 12, 2024
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study.

Sriram Deivasigamani, Eric S Adams, Shannon Stock

|Feb 22, 2024
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.

Ryan E Fecteau, Bridget F Koontz, Karen E Hoffman

Pageof 3

Frequent Collaborators

5 joint publications

Stephen J Freedland

4 joint publications

Michael R Harrison

4 joint publications

Daniel J George

4 joint publications

Amanda M De Hoedt